AzTrials
AzTrials

MoralityNCT06530095

We Compared the Covid-19 Acute Respiratory Distress Syndrome (ARDS) Patients Who Applied Prone Positioning for16-24 Hours vs 24-48 Hours

An observational study of Morality and Oxygenation Indices, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to understand if there is any improvement on oxygenation of patients diagnosed with Covid-19 ARDS patients when we extend the duration of prone positioning. Second outcome of the study is to investigate mortality of patients when we extend the duration of prone positioning. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Morality, Oxygenation Indices, Hypoxia
What is being tested?
prone positioning
How many people
350 participants
Where
1 siteTurkey (Türkiye)
Study dates
3 Oct 2022to 15 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who have been admitted in ICU and diagnosed with Covid-19 ARDS.

Who may be able to join

  • COVİD 19 ARDS patients patients who have been intubated for 48 hours and more

Who cannot join

  • Pediatric patients Patients who extubated in less than 48 hours Patients with Lung and pleural malignancies

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bakirkoy Dr Sadi konuk Research and Training hospital

    Istanbul, 34450

Other trials in Turkey (Türkiye)

About this study

Official title: ''Impact of Early vs. Delayed Prone Positioning on Oxygenation and Mortality in COVID-19 ARDS Patients: A Retrospective Analysis''

The goal of this study is to understand if there is any improvement on oxygenation of patients diagnosed with Covid-19 ARDS patients when we extend the duration of prone positioning.

Second outcome of the study is to investigate mortality of patients when we extend the duration of prone positioning.

Being tested
prone positioning
Medical subject headings
Hypoxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • prone positioningOther

    prone positioning

Study groups in NCT06530095
Study groupRoleWhat they receive
Group APatients who have been in prone positioning for 16-24 hours
Receives: Other: prone positioning
Group BPatients who have been in prone positioning for 24-48 hours
Receives: Other: prone positioning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygen Saturation Index (OSI)

    OSI is calculated by dividing the product of mean airway pressure (MAP) and FiO2 with SpO2

    Measured: 48 hours

  2. Oxygenation Index

    Oxygenation index is calculated as OI = MAP × Fio2 × 100 / Pao2, where MAP indicates mean airway pressure and Fio2 indicates fraction of inspired oxygen

    Measured: 48 hours

Secondary outcomes (1)
  1. ICU mortality

    mortality rates during patients admission in the ICU

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2024
  2. Study start3 Oct 2022
  3. Primary completion3 Jan 2023
  4. Study completion15 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
350 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06530095
Sponsor's protocol ID
2022/318
Status last verified
Jul 2024
First submitted
30 Jul 2024
Last updated
31 Jul 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Morality and Oxygenation Indices, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygen Saturation Index (OSI) (time frame: 48 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in